NYSE Arca · BBP

Virtus Biotech ETF (BBP)

$105.02+0.34%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$105.02▲ 51.47% in range
Sep 29, 2025Low $69.33 · High $109.90Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

Virtus Biotech ETF closed at $105.02 on Sep 28, up 0.34%, 4.4% below its 52-week closing high. Volume of 17.5K shares was 1.51× its 20-day average (above normal).

Split-adjusted performance: -3.4% over one month, +33.6% over six months, +54.2% over one year.

Short interest was 3.3K shares at the Sep 15 settlement, down 87.9% from the prior report (1.0 days to cover).

Market cap$126.0M1.2M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yieldNone$0.0723 last paid
52-week range68.13 – 109.90−4.4% from high
Volume17.5K1.51× 20-day avg
Volatility · 60d26.6%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −0.2%1M −3.4%3M +9.3%6M +33.6%YTD +31.4%1Y +54.2%3Y +110.9%5Y +103.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short3.3K−87.9% vs prior
Days to cover1.0Settled Sep 15
% of float—
Short vol. 10d41.0%of daily volume

News about Virtus Biotech ETF

All news →

No recent articles focused on Virtus Biotech ETF. 1 articles mention it in passing.

Quick answers

What is BBP's market cap?
$126.02M, based on the Sep 28 close of $105.02.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology